BERLIN -- German stocks were off to a shaky start on Monday, with the benchmark DAX index losing 118.05 points, or 0.90 percent, opening at 12,998.90 points.
The biggest winner among Germany's largest 30 companies at the start of trading was pharmaceutical company Merck, increasing by 0.36 percent. Utility RWE and online food delivery company Delivery Hero followed, both falling by 0.26 percent. (Germany-Stock-Share)
- - - -
SYDNEY -- The Australian share market slid to a near three-month low on Monday, as losses in heavyweight mining and bank sectors weighed.
At the market close the benchmark S&P/ASX 200 index was down 41.90 points or 0.71 percent at 5,822.60, its lowest level since June 29, while the broader All Ordinaries index was down 44.10 points or 0.73 percent at 6,013.50. (Australia-Stock Market News)
- - - -
WELLINGTON -- The New Zealand government has committed to investing 27 million NZ dollars (18.3 million U.S. dollars) in COVID-19 vaccine development through the global COVAX Facility, Deputy Prime minister and Foreign Minister Winston Peters said on Monday.
"The COVAX Facility is a key part of our COVID-19 Vaccine Strategy to obtain safe and effective vaccines. It allows us to invest in a high-quality, diversified portfolio of COVID-19 vaccine candidates. This will ensure we are spreading risk and keeping our options open," Peters said in a statement. (New Zealand-COVID-19 Vaccine-Investment)
- - - -
NEW YORK -- U.S. stocks continued to drop on Friday as market sentiment was dampened by mixed economic data and geopolitical concerns.
The Dow Jones Industrial Average fell 244.56 points, or 0.88 percent, to 27,657.42. The S&P 500 dropped 37.54 points, or 1.12 percent, to 3,319.47. The Nasdaq Composite Index decreased 116.99 points, or 1.07 percent, to 10,793.28. (US-Stocks)